The contrast between the relative efficiency of transfection each type of cationic lipid complex, but there was no differby cationic lipid reagents in vitro and that in vivo is well ence in the amount nor in the type of protein bound. DNA recognised. One suggested reason for this is the presence within either type of complex which were incubated with of competing polyanionic surfaces in blood and other bioincreasing amounts of serum remained resistant to digeslogical fluids, and even in vitro transfections have to be tion with DNase I, and there was no reduction in the conperformed in low-serum medium. In this study we have densation of the DNA as measured by ethidium bromide shown that by preparing cationic lipid reagents based on fluorescence. Finally, we measured the attachment and DOTAP with cholesterol as a second constituent of the uptake into cells by the different complexes in the presence bilayer we can achieve significant levels of in vitro transfecof serum and showed that more DOTAP-cholesterol than tion in serum concentrations of up to 80% (DOTAP alone DOTAP complexes attach to and are taken up by cells in did not transfect at all in these conditions). In an effort to the presence of serum. We suggest that improved cell explain the behaviour of DOTAP/cholesterol mixes under binding and uptake may be the main mechanism by which these conditions, we examined the effect of serum on the cholesterol acts to maintain transfection in the presence transfection complex. We could detect protein bound to of serum.
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The use of cationic lipids as reagents for transfections, epithelial lining fluid in the lung) may coat the cationic lipid complex, which normally bind to their target cells both in vitro and in vivo, is becoming the preferred choice in many laboratories.
1 In vitro, they offer high efficiency by a purely electrostatic interaction. The coated complexes would thus be impeded from interacting with the of transfection linked to a very simple protocol requiring no special skill or equipment. For in vivo studies and surface of the target cells and gene delivery thereby reduced. Indeed, in vitro transfection protocols routinely particularly gene therapy procedures, they are preferred by some investigators to recombinant viruses because of require that the target cells are exposed to the cationic lipid complexes in the absence of serum, another rich their perceived relative higher safety. Data from experimental animals and anecdotal evidence from much source of polyanionic molecules. A second possibility is that serum proteins cause some kind of structural reorhuman work indicate that the recombinant adenovirus initiates an immune response in the host, reducing or ganisation of transfection complexes (as has been shown for poly-l-lysine (PLL) complexes; L Seymour, personal even ablating, gene expression from the delivered DNA.
2
On the other hand, cationic lipids are, as far as is known, communication), which in turn reduces the ability of the complex to deliver DNA efficiently to cells. poorly immunogenic and there is no evidence for a host immune response induced by the lipid. In contrast to in Recent data have demonstrated that in vivo transfection with the cationic lipid DOTAP is much more efficient vitro transfections though cationic lipid-mediated gene delivery to in vivo targets is inefficient. For example, in when cholesterol is included in the formulation. 6-8 However, there is as yet no explanation for this improved perthe case of gene therapy for cystic fibrosis, results from clinical trials using lipids, while demonstrating a lack of formance and such an understanding would allow a more rational approach to the design of stable in vivo toxicity, have been no more successful than recombinant adenovirus in terms of efficiency of gene delivery.
3-5 The gene delivery vehicles.
9
It has long been known that cholesterol will improve reasons for this in vivo inefficiency are unknown, but one possibility may be that the abundance of polyanionic the stability of neutral and anionic lipid liposomes 10 and recent data have shown that the half-life of such lipomolecules in serum or other physiological fluids (such as somes in the circulation of mice can be increased by the inclusion of cholesterol in the liposome. 11 These workers showed that less protein became bound to cholesterol-system. In another piece of work, Plank et al 12 demonof complexes with FCS and then separated the complexes from serum by centrifugation. Protein and lipid phases strated that by varying the constituents of cationic lipid formulations, the amount of complement bound and actiwere separated as described in the legend to Figure 3 and divided into two aliquots: one was used in a BCA protein vated at the complex surface also varied. Since complement components are important opsonins, it is likely assay and the other was analysed by SDS-PAGE. Measuring the protein concentration associated with each type that increased complement binding would lead to decreased in vivo half-life.
of complex did not reveal any difference between the two (DOTAP 82 ± 60 g/ml; DOTAP/cholesterol 78 ± 33 In the present study we have prepared DOTAP cationic lipid complexes containing cholesterol and tested g/ml; levels were based on the standard curve for bovine serum albumin). Similarly, SDS-PAGE did not show their gene delivery ability under in vitro conditions that are normally refractory to lipid-mediated transfection.
any obvious differences between the types of proteins associated with the two complex formulations, with the The effect on complex stability of inclusion of cholesterol in the lipid formulation in the presence of serum was also pattern of banding seen being similar to that in whole serum ( Figure 3 ). It is possible, though, that the assays examined. We also measured the binding of the different complexes to cells in the presence of serum, as well as used here may not have been sufficiently sensitive to detect small or specific differences in protein binding. their uptake into cells. In attempting to understand the modified behaviour of complexes including cholesterol in Preliminary studies carried out on a Malvern Zetasizer 3000 (Malvern Instruments, Malvern, UK) have indicated the presence of serum, we believe that our findings may be a useful contribution in the design of nonviral reagents that DOTAP and DOTAP/cholesterol complexed with DNA have mean sizes of 707.1 nm and 1677.2 nm, for in vivo gene delivery.
Initial studies with transfections performed in increasrespectively. On addition of serum to a final concentration of 50%, these sizes dropped to 568.6 nm and 737.9 ing amounts of serum from different species were carried out using DOTAP mixed with cholesterol in varying pronm, respectively. Although these results are suggestive of a size difference in complexes formed in the presence portions (transfection complexes were always prepared with a ratio of 12:1 DOTAP:DNA w/w, previously demor absence of serum, the limitations of photon correlation spectroscopy (PCS) analysis must be borne in mind and onstrated to be optimal for transfection 13 ). The results shown in Figure 1 demonstrated that DOTAP alone was further studies are required to confirm these initial findings. less efficient at delivering DNA to cells in the presence of increasing concentrations of foetal bovine serum. HowSome recent work has suggested that DNA-polycation complexes may become destabilised in contact with polyever, as cholesterol was included in the complex in increasing amounts, the transfection level increased draanions and serum proteins 12,15 and this could potentially lead to reduced transfection efficiency. We asked whether matically. At DOTAP:cholesterol ratios of 1:2, 1:1 and 2:1 (w:w) transfection in the presence of 5-10% serum was we could observe such a destabilisation with DOTAP-DNA complexes and whether the inclusion of cholesterol much more efficient than with DOTAP complexes alone. When the serum concentration was increased to 40 and in the bilayer with DOTAP might inhibit or reduce this. Lipid-DNA complexes were formed with either DOTAP 80%, the efficiency of transfection dropped to lower levels for DOTAP/cholesterol mixes, but was reduced or DOTAP:cholesterol (1:1) and then exposed to 100% FCS (80% final). The complexes were then incubated with towards background for DOTAP alone. The presence of cholesterol at a proportion of less than 25% in the comDNase I and following this the complex was dissociated with SDS. 16 Figure 4 agrees with other studies we have plex (relative weight to DOTAP) did not preserve transfection in higher serum concentrations. All these differpresented 13 and shows that at a ratio of 12:1 DOTAP:DNA (w/w) there is some unbound DNA (in ences in expression of reporter gene were reflected in the numbers of cells expressing transgene product (Figure 2 ). supercoiled and relaxed circular forms -lower and upper migrating bands, respectively) which migrates into the DOTAP in the presence of 50 and 100% serum resulted in less than 1% of transfected cells, whereas gel while ethidium bromide staining in the wells is presumed to represent DNA-lipid complexes which are too DOTAP/cholesterol (1:1 w:w) gave levels of approximately 5 and 8%, respectively. The results shown in 13 and 15, and lanes 14 and 16) . however, we could not demonstrate a benefit of cholesterol inclusion in cationic lipid complexes on transfection Transfection assays in vitro demonstrated that there is little difference in the level of reporter gene activity when in low serum conditions. Entirely similar results were obtained with human and horse serum (not shown), sugthe complexes are incubated with serum alone and with serum and DNase ( Figure 5 ). Using analysis by Student's gesting the phenomenon is not specific to foetal calf serum. The results cannot be explained by differing toxt test, no significant differences were observed between results with or without DNase in four different experiicities of the formulations or of the serum, since cell viability counts showed that these had no differential ments. These data suggest that DNA associated with either type of complex is completely resistant to the effects (data not shown).
At the outset of these studies, we hypothesised that action of DNase. As a second index of complex stability we measured cationic lipid reagents did not transfect well in serum because of the presence of other polyanionic surfaces the effect of serum on the ethidium bromide fluorescence of DNA within the complex. It is already well established which became attached to the cationic lipid complexes and prevented them binding to target cells. To test that when DNA forms a complex with either cationic lipids or PLL, associated ethidium bromide staining is whether DOTAP-cholesterol complexes bound less protein than DOTAP complexes we incubated the two types lost. 13,15,17 More recent studies (Seymour W, personal communication) have suggested that serum proteins serum, the mean channel fluorescence was much greater for DOTAP-cholesterol, suggesting that more of these cause a reorganisation of DNA-PLL complexes and a reappearance of the ethidium bromide fluorescence. Our complexes were associated with cells. Following protease treatment to remove any surface-bound complex, it was own studies have shown that when DNA is prestained with ethidium bromide and then complexed with clear that as the concentration of serum increased, the number of cells containing DOTAP complexes decreased. DOTAP, the ethidium bromide is still contained within the complex even though the fluorescence is somehow For DOTAP-cholesterol on the other hand, the number was maintained up to a level of 80% serum when it also masked (K.C. unpublished data). However treatment with serum of DOTAP or DOTAP-cholesterol complexes began to diminish, while still remaining greater than that for DOTAP alone. It was also noticeable that as the concontaining ethidium bromide-stained DNA did not lead to any reappearance of fluorescence signal from DNA.
Figure 1 Transfection in serum with varying ratios of DOTAP:cholesterol. DOTAP was mixed with cholesterol in varying proportions and complexed with DNA (at 12:1, DOTAP:DNA, w:w). These complexes were then exposed to Cos7 cells in the presence of increasing concentrations of foetal calf serum. The 'zero' refers to transfection in the presence of Optimem. DOTAP:cholesterol ratios are weight:weight. DOTAP was obtained as a powder both commercially from Avanti Polar Lipids and as a generous gift from Dr U Michaelis (Boehringer Mannheim, Penzberg, Germany). Cholesterol was supplied by Sigma Chemical. Lipid and cholesterol were dissolved in chloroform and mixed in the appropriate ratios (usual preparations were based around 1 mg of DOTAP). Excess solvent was evaporated in a stream of nitrogen and the lipid film taken to complete dryness in a freeze
centration of serum increased, the mean channel fluorescence increased as well. Although the 'internal' mean These data suggest that DOTAP and DOTAP-cholesterol complexes with DNA may be more stable in the presence channel fluorescence also increased slightly, it began to drop at 80% serum. Thus it would appear that as the of serum than PLL complexes.
DOTAP and DOTAP-cholesterol complexes were serum concentration increases, the number of DOTAPcholesterol complexes attaching to the cells continues to made containing 1% (molar ratio relative to DOTAP) DOPE-NBD. This extra lipid had no effect on reporter increase, though at high concentrations of serum, the amount being endocytosed diminishes. We have no gene activity (not shown) but did allow the measurement by flow cytometry of complexes bound to and inside explanation for this increased binding. Since the level of transfection drops as serum increases (see Figure 1 ) it was cells. Table 1 shows that although around 70-90% of all cells bound both types of complex in the presence of perhaps surprising to see as many complexes inside the become susceptible to digestion by serum-derived nucleases (a possibility already raised in other work 18 ). The higher the concentration of serum in the surrounding metry results demonstrated that the inclusion of cholesterol within the complex permitted more complex to bind medium, the more important will be that degradation.
Overall, our data suggest that the stability of the comto cells in the presence of serum, and we suggest that this may be enough to explain the improved transfection plex itself, whether containing cholesterol or not, was unaffected by the presence of serum. However, flow cytoefficiency of DOTAP-cholesterol complexes. Serum (a) % Cells positive DOTAP (internal) 56 ± 1 6 1 ± 3 6 2 ± 5 4 8 ± 1 3 9 ± 1 DOTAP/chol (internal) 50 ± 9 7 9 ± 3 7 7 ± 3 8 0 ± 8 5 8 ± 9 DOTAP (total) 67 ± 4 8 8 ± 0 8 6 ± 10 89 ± 7 8 7 ± 10 DOTAP/chol (total) 76 ± 1 8 9 ± 3 7 4 ± 8 9 0 ± 5 8 6 ± 4 (b) Mean channel fluorescence DOTAP (internal) 87 ± 3 6 6 ± 6 8 7 ± 3 7 8 ± 7 7 3 ± 11 DOTAP/chol (internal) 120 ± 2 143 ± 8 182 ± 1 245 ± 16 221 ± 24 DOTAP (total) 162 ± 2 140 ± 36 177 ± 35 194 ± 19 217 ± 32 DOTAP/chol (total) 230 ± 65 266 ± 43 347 ± 45 479 ± 128 584 ± 32 DOTAP and DOTAP-cholesterol (1:1, w:w) were prepared as described in the legend to Figure 1 , except that 1% (weight equivalent) of DOPE-NBD (Avanti Polar Lipids, Alabaster, AL, USA) also dissolved in chloroform/methanol was included. After the complexes had been in contact with the cells for 5 h the cells were removed by trypsinisation and divided into two aliquots. One was washed three times in PBS (Dulbecco A tablets; Oxoid, Basingstoke, UK) containing 0.1% bovine serum albumin and 0.01 m sodium azide, keeping the cells at 4°C or on ice at all times (to prevent further internalisation of surface-bound complexes) and left for subsequent flow cytometric analysis using a Becton Dickinson FACScan (Mountain View, CA, USA). The second aliquot of cells was washed three times in the same handling medium and then incubated at 4°C for 1 h in 1.5 mg/ml protease (type XIV; Sigma Chemical, Poole, UK). One millilitre of protease was added for each aliquot of cells. The reaction was stopped by adding 2 ml of PBS containing 20% (final) FCS. The cells were washed in handling buffer and analysed by flow cytometry as above. 'Total' in the above Table refers to the amount of fluorescence associated with the transfected but non-protease-treated cells and is a measurement of the number of complexes associated at the cell surface as well as those which have been internalised. 'Internal' refers to measurements from cells which have been protease treated and indicates the numbers of complexes which have been internalised. Preliminary experiments suggested that the above protease treatment removed all proteins from the cell surface, and thus any bound transfection complexes. Data (from two representative experiments) are presented in two ways: (a) % cells positive, which refers to the total numbers of cells registering any fluorescence (after subtracting an untransfected control); (b) mean channel fluorescence, which refers to the mean brightness of the total number of positive cells. The brighter the signal, the more complex is associated with the cell.
